Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie van Tol

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Metabolism: Clinical and Experimental|December 19, 2002
Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and womenNicole M de Roos, Evert G Schouten, Leo M Scheek, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 22, 2003
Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer proteinSabine M Post, Rini de Crom, Rien van Haperen, et al.
Clinical Endocrinology|September 20, 2007
Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminasesRobin P F Dullaart, Rindert de Vries, Geesje M Dallinga-Thie, et al.
Atherosclerosis|June 8, 2002
Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol effluxMaryse Guerin, Pascal Egger, Céline Soudant, et al.
Diabetes|April 29, 2006
Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?Geesje M Dallinga-Thie, Arie van Tol, Hiroaki Hattori, et al.
Journal of Lipid Research|October 5, 2002
Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial stateMaryse Guerin, Pascal Egger, Céline Soudant, et al.
Clinical Laboratory|August 27, 2005
Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjectsRindert De Vries, Bruce H R Wolffenbuttel, Wim J Sluiter, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2005
Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatmentLiffert Vogt, Gozewijn D Laverman, Arie van Tol, et al.
The Journal of Dairy Research|May 25, 2005
Fatty liver in dairy cows post partum is associated with decreased concentration of plasma triacylglycerols and decreased activity of lipoprotein lipase in adipocytesA Marc Van den Top, Arie Van Tol, Hans Jansen, et al.
Alcoholism, Clinical and Experimental Research|September 28, 2002
Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumersAafje Sierksma, Martijn S van der Gaag, Arie van Tol, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Metabolism: Clinical and Experimental|December 19, 2002
Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and womenNicole M de Roos, Evert G Schouten, Leo M Scheek, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 22, 2003
Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer proteinSabine M Post, Rini de Crom, Rien van Haperen, et al.
Clinical Endocrinology|September 20, 2007
Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminasesRobin P F Dullaart, Rindert de Vries, Geesje M Dallinga-Thie, et al.
Atherosclerosis|June 8, 2002
Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol effluxMaryse Guerin, Pascal Egger, Céline Soudant, et al.
Diabetes|April 29, 2006
Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?Geesje M Dallinga-Thie, Arie van Tol, Hiroaki Hattori, et al.
Journal of Lipid Research|October 5, 2002
Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial stateMaryse Guerin, Pascal Egger, Céline Soudant, et al.
Clinical Laboratory|August 27, 2005
Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjectsRindert De Vries, Bruce H R Wolffenbuttel, Wim J Sluiter, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2005
Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatmentLiffert Vogt, Gozewijn D Laverman, Arie van Tol, et al.
The Journal of Dairy Research|May 25, 2005
Fatty liver in dairy cows post partum is associated with decreased concentration of plasma triacylglycerols and decreased activity of lipoprotein lipase in adipocytesA Marc Van den Top, Arie Van Tol, Hans Jansen, et al.
Alcoholism, Clinical and Experimental Research|September 28, 2002
Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumersAafje Sierksma, Martijn S van der Gaag, Arie van Tol, et al.
Pageof 6